Unknown

Dataset Information

0

Dramatic Effect of Oral CSF-1R Kinase Inhibitor on Retinal Microglia Revealed by In Vivo Scanning Laser Ophthalmoscopy.


ABSTRACT: This report provides sound evidence that the small molecule pharmaceutical PLX5622, a highly selective CSF-1R kinase inhibitor, crosses the blood-retina barrier and suppresses microglia activity. Members of this class of drug are in advanced clinical development stages and may represent a novel approach to modulate ocular inflammatory processes.

SUBMITTER: Ebneter A 

PROVIDER: S-EPMC5407246 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dramatic Effect of Oral CSF-1R Kinase Inhibitor on Retinal Microglia Revealed by In Vivo Scanning Laser Ophthalmoscopy.

Ebneter Andreas A   Kokona Despina D   Jovanovic Joël J   Zinkernagel Martin S MS  

Translational vision science & technology 20170419 2


This report provides sound evidence that the small molecule pharmaceutical PLX5622, a highly selective CSF-1R kinase inhibitor, crosses the blood-retina barrier and suppresses microglia activity. Members of this class of drug are in advanced clinical development stages and may represent a novel approach to modulate ocular inflammatory processes. ...[more]

Similar Datasets

| S-EPMC6854902 | biostudies-literature
| S-EPMC4259836 | biostudies-literature
| S-EPMC2911957 | biostudies-literature
| S-EPMC5954931 | biostudies-literature
| S-EPMC7225615 | biostudies-literature
| S-EPMC3114227 | biostudies-other
| S-EPMC4507481 | biostudies-literature
| S-EPMC3299751 | biostudies-literature
| S-EPMC6137139 | biostudies-literature
| S-EPMC5557086 | biostudies-other